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Use of Balloon Pull-Through Technique to Assist in
CardioSEAL Device Closure of Patent Foramen Ovale
Kavitha Chintala,1 MD, Daniel R. Turner,1 MD, Stephanie Leaman,1 Edwin Rodriguez-Cruz,1 MD,
Joshua Wynne,2 MD, Adam Greenbaum,3 MD, and Thomas J. Forbes,1* MD
CardioSEAL device closure of patent foramen ovale (PFO) has been advocated for the
treatment of patients with cryptogenic stroke. Using the standard delivery technique,
partial deployment of the CardioSEAL device can occur, especially in patients with a thick
septum secundum and/or long PFO tunnel. We hypothesized that using a left atrial-to-
right atrial balloon pull-through to make the septum primum incompetent would result in
improved final device position regardless of septal thickness or tunnel length. Catheter-
ization reports, cineangiograms, and transesophageal echocardiograms of 51 patients
who underwent CardioSEAL device closure of PFO between March 2000 and August 2002
were retrospectively reviewed. Group 1 (n  21) included patients with CardioSEAL
placement using the standard technique and group 2 (n  30) included patients with
CardioSEAL placement using the balloon pull-through technique. There were no differ-
ences between the groups in terms of age (43.6 vs. 45.3 years; P  NS), weight (83.3 vs.
89.9 kg; P  NS), septum secundum thickness (6.4 vs. 7.0 mm; P  NS), PFO tunnel length
(15.5 vs. 13.1 mm; P  NS), or device size. In group 1, 4/21 (19%) had partial deployment
of the CardioSEAL device, while in group 2, no partial CardioSEAL deployment (0/30) was
observed. No complications were associated with the balloon pull-through technique. We
conclude that the left atrial-to-right atrial balloon pull-through technique is safe and may
allow for better final position of the CardioSEAL device during PFO closure. Catheter
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INTRODUCTION
Patent foramen ovale (PFO) diagnosed by transesoph-
ageal echocardiography (TEE) is present in approxi-
mately 10% of a controlled population [1] and in 30% of
patients with cerebrovascular accident or transient isch-
emic attacks [2]. Until the last decade, surgical PFO
closure or anticoagulation therapy was used in patients
presumed to have paradoxical embolus as the etiology of
their stroke [3,4]. Recently, transcatheter PFO closure
using various devices has become increasingly popular,
with a few small studies suggesting reduction in stroke
recurrence during a short-term follow-up [5–7], with
several other large-scale prospective randomized trials
being in place. The CardioSEAL device (Nitinol Medical
Technologies, Boston, MA) is a non-self-centering de-
vice approved for use in the United States under a Hu-
manitarian Device Exemption (HDE) protocol since Feb-
ruary 2000.
Certain anatomical characteristics of septum primum and
septum secundum may preclude optimal CardioSEAL de-
vice positioning during closure of PFO. Improper final
device position may be related to a long PFO tunnel length
and/or a thick septum secundum. When the degree of over-
lap between septum primum and septum secundum is large,
the long PFO tunnel that has to be traversed may potentially
cause deformity of the left atrial umbrella before complete
deployment of the right atrial side when using the standard
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technique. One or both umbrellas may become trapped
within the PFO tunnel. A thick septum secundum may also
preclude proper device position by preventing the right
atrial umbrella from lying flush against the septum. These
difficulties have prompted some to use transseptal technique
to position the CardioSEAL device properly [8]. This article
describes a new technique that involves a left atrial-to-right
atrial balloon pull-through to help achieve proper Cardio-
SEAL device position during transcatheter closure of PFO.
MATERIALS AND METHODS
Study Population
The study population included 51 patients who under-
went transcatheter closure of PFO using the CardioSEAL
device at our institution between March 2000 and August
2002. The indication for PFO closure was single cere-
brovascular accident in 33 patients, multiple cerebrovas-
cular accidents in 7 patients, multiple transient ischemic
attacks in 4 patients, cerebrovascular accident and tran-
sient ischemic attack in 4 patients, and platypnea-orth-
odeoxya syndrome in 3 patients. Three patients had a
hypercoagulable state secondary to malignancy and three
patients had history of migraine headaches. Each cere-
brovascular accident was cryptogenic in nature. The di-
agnosis of PFO was made by TEE with or without the use
of agitated saline contrast. The anticoagulation regimen
prior to device closure consisted of coumadin in about
half the patients, aspirin in a quarter, and clopidogrel
(Plavix) or a combination of antiplatelet and anticoagu-
Fig. 1. Pathologic reproduction of the balloon pull-through technique. The pictures were taken from the posterior aspect of the
specimen. A shows the balloon catheter crossing the PFO from the right atrium (RA) to the left atrium (LA). Septum primum (SP)
overlaps septum secundum to form the PFO tunnel. B depicts the inflated balloon being pulled through the PFO, everting septum
primum. C demonstrates a compliant septum primum and a shorter PFO tunnel length. [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com].
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lant medications in the other quarter of patients as deter-
mined appropriate by their neurologist. Patients were
divided into two groups based on the technique used to
place the CardioSEAL device.
Catheterization Procedure: Standard Technique
Written informed consent was obtained from all pa-
tients. The procedure was performed using general anes-
thesia with TEE guidance or under conscious sedation
with fluoroscopic guidance. All patients received sys-
temic heparin during the procedure to maintain an acti-
vated clotting time of more than 275 sec.
Right heart catheterization was performed and hemo-
dynamic data were derived. Angiograms were performed
in the right atrium or within the PFO tunnel to delineate
the anatomy. A long sheath was advanced over a wire to
the inferior vena caval/right atrial junction. The dilator
was removed and the sheath was cleared of air and
flushed with heparinized saline before it was advanced
over the wire to the left upper pulmonary vein. The
CardioSEAL device attached to a delivery system was
advanced to the tip of the sheath. The left atrial umbrella
was deployed and the device was pulled back so that the
center pin was within the PFO tunnel. After angiography
through the sheath documented satisfactory device posi-
tion, the right atrial umbrella was delivered by withdraw-
ing the sheath. After device release, an angiogram was
performed in the right atrium.
Balloon Pull-Through Technique
After crossing the PFO and positioning a wire in the
left upper pulmonary vein, a 7 Fr balloon wedge catheter
was advanced over the wire to the left atrium. The wedge
balloon was inflated with 2 cc of diluted contrast and the
catheter was pulled back over the wire through the PFO
to the right atrium (Fig. 1). This maneuver was per-
formed two to three times in an attempt to evert or
increase the compliance of septum primum. This was
followed by device delivery as described above.
Angiographic Measurements and Device Position
Angiographic measurements included PFO tunnel
length, defined as the degree of overlap between the
septum primum and septum secundum, and thickness of
the septum secundum, which was measured at the mid-
point of the tunnel (Fig. 2). Fluoroscopic images were
reviewed to determine final device position. Satisfactory
device position was achieved when each side of the
device remained in contact with the atrial septum (Fig.
3). Poorly positioned devices included those where the
right or left atrial umbrellas were flexed away from the
atrial septum (Fig. 4).
Follow-Up
Those patients who were on coumadin (or clopidogrel)
prior to the procedure were placed on a regimen of
coumadin (or clopidogrel) and aspirin for 2 months and
aspirin alone for the following 4 months. Patients who
took aspirin prior to device placement were continued on
the same medication for at least 6 months and subsequent
need for anticoagulation was decided by the neurologist.
All patients had chest X-ray, electrocardiogram, and
transthoracic echocardiography performed prior to dis-
charge to confirm device position and to assess for the
presence of any residual shunting. Follow-up consisted
of clinical assessment, chest X-ray, and a transthoracic
echocardiogram (without bubble study).
Statistical Analysis
The nonpaired Student’s t-test was used to evaluate
differences in dependant variables between the two




A total of 51 patients aged 16 to 83 years were in-
cluded in the study. Group 1 (n  21) consisted of
patients who had CardioSEAL placement using the stan-
dard technique and group 2 (n  30) consisted of patients
Fig. 2. PFO tunnel length measured as the degree of overlap
between septum primum and septum secundum. Septum se-
cundum thickness measured at the midpoint of the PFO tunnel.
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who had CardioSEAL placement after the balloon pull-
through technique. There were no significant differences
in patient demographics, PFO anatomy, or device size
between the groups (Table I). There were no procedural
complications in either group.
Device Position
In group 1, 4/21 patients (19%) had poor device po-
sition as defined above. No patient in group 2 (0/30) had
a poorly positioned device (Table II; P  0.01). Patients
in group 1 with poorly positioned devices using the
standard technique had PFO tunnel lengths  15 mm
(Table III). All patients in group 2 with similar PFO
tunnel lengths had satisfactory device position with use
of the balloon pull-through technique.
Follow-Up Events
None of the patients had embolization of the device.
During a median follow-up of 17.5 months (range, 1–30
months), two patients in group 1 had recurrence of neu-
rological events. The first patient had a hypercoagulable
state secondary to ovarian carcinoma and developed a
stroke the evening of the device placement. She subse-
quently died 2 months later of advanced metastatic can-
cer. The second patient with no known identifiable risk
factors had a transient ischemic attack 3 months after
device placement, with no recurrent events at 18-month
follow-up. Both these patients had good device position
and absence of residual shunt at discharge.
Follow-Up Echocardiography
Echocardiographic evaluation with color Doppler at
discharge revealed the presence of trivial to small shunts
in 11 patients (6 in group 1 and 5 in group 2). Follow-up
echocardiography at a median of 9 months (range, 1–30
months) showed resolution of these residual shunts in all
except two patients (one from each group), where they
persisted to be small in size. Both these patients remain
free of recurrent neurological events. Among the four
patients in group 1 that had a poorly positioned device,
only one had residual shunt at follow-up.
DISCUSSION
Successful device closure of PFO in patients with
cryptogenic stroke should interrupt the presumed path-
way of paradoxical embolus by effective anatomic ap-
proximation of septum primum and septum secundum
Fig. 3. Diagrammatic (A) and angiographic (left anterior oblique projection; B) representation of a CardioSEAL device in satis-
factory position with each arm well flexed against the atrial septum.
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and by rapid and complete endothelialization of the de-
vice. A device that is in an optimal position with each
arm well apposed to the atrial septa facilitates this pro-
cess. An improperly positioned device may result in
device embolization, delayed or incomplete endothelial-
ization, thrombus formation, or an increased likelihood
of residual shunting through the PFO. The latter has been
shown to predispose to recurrent cerebrovascular acci-
dents after PFO device closure [9].
The CardioSEAL device has been used extensively for
transcatheter closure of PFO in patients with cryptogenic
stroke. Poor device position may occasionally occur us-
ing the standard delivery technique and is more likely to
happen in patients with unfavorable PFO anatomy, which
includes a long PFO tunnel and a thick septum secun-
dum. In order to achieve satisfactory device position,
some investigators have advocated the use of transseptal
technique [8]. We hypothesized that optimal device po-
sition may also be achieved by the use of a simple
balloon pull-through technique.
It has been shown that PFO tunnel length shortens or
disappears completely by inferior displacement of sep-
tum primum after placement of a non-self-centering de-
vice [10]. The balloon pull-through technique as de-
scribed in this study facilitates the process of shortening
PFO tunnel length either by everting or folding the sep-
Fig. 4. Diagrammatic (A) and angiographic (left anterior oblique projection; B) representation of a poorly positioned CardioSEAL
device with its arms flexed away from the atrial septum.
TABLE I. Comparison of Demographic Variables and PFO
Anatomy*
Standard technique
(group 1; n  21)
Balloon pull-through
technique
(group 2; n  30) P
Age (years) 43.6  15.5 45.3  15.1 0.7
Weight (kg) 83.3  16.6 89.9  39.2 0.4
Tunnel length (mm) 15.5  4.9 13.6  4.5 0.07
Septal thickness (mm) 6.4  1.9 7.0  1.9 0.3
*Values are mean  SD.







Standard (1) 21 17 (81) 4 (19)
Balloon pull-through (2) 30 30 (100) 0 (0)
aP  0.013.
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tum primum or by increasing its compliance prior to
device placement. In this study, all patients who under-
went the balloon pull-through technique had satisfactory
final device position as compared to only 17 out of 21
patients where the device was delivered using standard
technique.
We have noted in our study that each of the four
patients who had poorly positioned devices after standard
delivery technique had PFO tunnel lengths of 15 mm or
more. Conversely, it may be said that satisfactory device
position may be achieved in patients with shorter PFO
tunnel lengths irrespective of the technique used. The
difference in outcome (device position) between the two
techniques was most significant at tunnel lengths of  14
mm. We therefore suggest that while the balloon pull-
through technique may be employed safely in all pa-
tients, it is especially useful in patients with PFO tunnel
lengths  14 mm.
The simple, quick, and uncomplicated nature of this
balloon pull-through technique makes it an attractive
method for optimal device placement and may obviate
the need for transseptal procedure during CardioSEAL
placement. Additional studies are needed, however, to
compare the efficacy and safety of these two techniques.
Our study is aimed at evaluation of catheter techniques
that improve final device position so that optimal endo-
thelialization of the device is achieved. Even though one
patient out of the four with poor device position had a
residual shunt in our study, the small number of patients
and the short duration of follow-up preclude us to draw
meaningful conclusions regarding the effect of device
position on residual shunt. Moreover, the recurrence of
neurological events in the absence of residual shunt in the
two patients outlines the difficulty in predicting recurrent
stroke risk in individual patients after device closure of
PFO. Large-scale randomized controlled trials are nec-
essary to address these issues.
In conclusion use of a simple balloon pull-through
technique to assist in transcatheter CardioSEAL device
closure of PFO in patients with cryptogenic stroke re-
sulted in improved final device position compared to
using the standard delivery technique. This procedure is
especially useful in patients who have long PFO tunnel
lengths.
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1 15.8 9.9 33 Right atrial
2 19.9 6.9 33 Right atrial
3 15.4 6.9 33 Right atrial,
left atrial
4 23.0 4.6 28 Right atrial
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